HCM Q1 2020 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

Q1 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$52M-1.1% YoY

Gross Profit

$10M19.9% margin

Operating Income

-$32M-63.0% margin

Net Income

-$16M-31.3% margin

EPS (Diluted)

$-0.24

QoQ Revenue Growth

-2.4%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$4M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$0

Total Liabilities

$0

Stockholders' Equity

$313M

Cash & Equivalents

-$220M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$52M	$52M	-1.1%
Gross Profit	$10M	$11M	-8.3%
Operating Income	-$32M	-$36M	+9.9%
Net Income	-$16M	-$20M	+18.8%